...
首页> 外文期刊>Experimental Eye Research >Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.
【24h】

Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.

机译:通过直接质谱法鉴定LOXL1蛋白和载脂蛋白E作为手术分离的假脱落材料的成分。

获取原文
获取原文并翻译 | 示例
           

摘要

Pseudoexfoliation (PEX) syndrome is the commonest cause of secondary glaucoma. Many extracellular matrix proteins and elastic fibre structure components are present in the pathological PEX deposits in the anterior segment of the eye including the anterior lens capsule. Common coding variants in the lysyl oxidase-like 1 (LOXL1) gene, involved in cross-linking elastin, have been reported to be strongly associated with PEX syndrome in various human populations. The mechanism by which the LOXL1 protein contributes to the formation of PEX material is unknown. A comprehensive map of the component proteins of PEX deposits can aid the understanding of disease pathogenesis. The purpose of this study was to identify additional protein constituents of pathological PEX deposits. We employed a novel proteomics approach by performing mass spectrometry on "isolated" PEX material surgically removed from the anterior lens capsule of affected eyes. This approach led to the identification of LOXL1 protein and Apolipoprotein E (ApoE) in PEX material. Previously identified protein constituents, latent-transforming growth factor beta-binding protein-2, complement 3 and clusterin were also detected. Immunohistochemical analysis of lens capsules from affected eyes confirmed the presence of both LOXL1 and ApoE in pathological PEX deposits. ApoE is a novel component of these deposits. This is the first report where a direct analytical approach has led to the identification of LOXL1 in PEX deposits and is consistent with its detection in these deposits by immunolabelling in another recent report. LOXL1 is both genetically associated with PEX syndrome and present in pathological PEX deposits. Hence it clearly has an important and direct role in pathophysiology of the disease. In conclusion, additional as yet unknown components are present in pathological PEX deposits and mass spectrometry of "isolated" PEX material is an effective strategy for their identification.
机译:假性剥脱(PEX)综合征是继发性青光眼的最常见原因。在包括前晶状体囊在内的眼前节的病理性PEX沉积物中存在许多细胞外基质蛋白和弹性纤维结构成分。据报道,参与交联弹性蛋白的赖氨酰氧化酶样1(LOXL1)基因的常见编码变异与人类各种人群中的PEX综合征密切相关。 LOXL1蛋白促进PEX物质形成的机制尚不清楚。 PEX沉积物组成蛋白的全面图谱可帮助您了解疾病的发病机理。这项研究的目的是确定病理性PEX沉积物的其他蛋白质成分。我们通过对从患病眼前晶状体囊手术切除的“分离的” PEX材料进行质谱分析,采用了一种新的蛋白质组学方法。这种方法导致鉴定了PEX材料中的LOXL1蛋白和载脂蛋白E(ApoE)。以前确定的蛋白质成分,潜在转化生长因子β结合蛋白2,补体3和丛集蛋白也被检测到。患眼晶状体囊的免疫组织化学分析证实,病理性PEX沉积物中同时存在LOXL1和ApoE。 ApoE是这些沉积物中的一种新颖成分。这是第一份直接分析方法已经鉴定出PEX沉积物中LOXL1的报告,并且与另一份最近的报告中通过免疫标记法在这些沉积物中的检测相一致。 LOXL1既与PEX综合征遗传相关,又存在于病理性PEX沉积物中。因此,它显然在疾病的病理生理学中具有重要而直接的作用。总之,病理性PEX沉积物中还存在其他未知成分,“分离的” PEX材料的质谱分析是鉴定它们的有效策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号